Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Rare inherited mutation in TP53 gene confers risk of multiple cancers

Rare inherited mutations in the body's master regulator of the DNA repair system – the TP53 gene – can leave people at a higher risk of developing multiple types of cancer over the course of their lives.

16 Jul 2020

NCI funds research surrounding sustainability of telemedicine for rural cancer patients

Telemedicine has been growing as a key mode of providing care to patients in rural areas. Now, the COVID-19 pandemic has led to an exponential increase in need to deliver care to patients with cancer and other chronic conditions remotely.

16 Jul 2020

Stand Up To Cancer announces new effort to achieve health equity for underserved lung cancer patients

Stand Up To Cancer today announced a new $5 million grant from Bristol Myers Squibb to fund research and education efforts aimed at achieving health equity for underserved lung cancer patients, including Black people and people living in rural communities.

16 Jul 2020

Promising new CAR T cell therapy results in exceptional patient recovery

In a clinical trial evaluating a novel immunotherapy option for cancer treatment, a child with rhabdomyosarcoma, a form of muscle cancer, that had spread to the bone marrow, showed no detectable cancer following treatment with chimeric antigen receptor (CAR) T cells that were engineered to target the HER2 protein on the surface of the cancer cells.

15 Jul 2020

Novotech webinar focuses on how to advance oncology clinical trials in the Asia-Pacific

The leading Asia-Pacific biotech specialist CRO Novotech is again collaborating with the prestigious biotech and pharma news platform Endpoints News. This webinar focusses on how to advance oncology clinical trials in the Asia-Pacific which is currently attracting 10,000 oncology studies.

From Novotech Pty Limited 15 Jul 2020

10x Genomics launches Chromium Single Cell Immune Profiling v2 product to fight COVID-19

10x Genomics strengthened the research toolkit of scientists around the globe today with the launch of its Chromium Single Cell Immune Profiling v2 product.

15 Jul 2020

Ashion's GEM ExTra assay receives Medicare coverage

Ashion Analytics LLC announced today that Palmetto GBA, a Medicare administrative contractor for the Molecular Diagnostic Services Program (MolDX), has awarded coverage to its proprietary cancer profiling test, GEM ExTra®, one of the nation's most comprehensive genomic cancer analysis tests.

15 Jul 2020

MD Anderson and Sanofi collaborate to accelerate development of innovative cancer therapies

The University of Texas MD Anderson Cancer Center and Sanofi today announced a five-year strategic collaboration to accelerate the development of investigational treatments, including targeted and immune therapies, for patients with cancer.

14 Jul 2020

Two new studies highlight possible treatment options for patients with neuroendocrine tumors

Two new studies led by Renuka Iyer, MD, Section Chief for Gastrointestinal Oncology at Roswell Park Comprehensive Cancer Center, highlight possible new treatment options for patients with neuroendocrine tumors (NETs) - a rare and hard-to-treat cancer.

14 Jul 2020

PSMA PET/CT has high impact in the detection, management of recurrent prostate cancer

New research confirms the high impact of PSMA PET/CT in the detection and management of recurrent disease in prostate cancer patients.

13 Jul 2020

Total-body dynamic PET can generate high-quality images of metastatic cancer

Results from the first study using uEXPLORER to conduct total-body dynamic positron emission tomography (PET) scans in cancer patients show that it can be used to generate high-quality images of metastatic cancer.

13 Jul 2020

Study shows safety and effectiveness of PET radiotracer in imaging glioblastomas

A first-in-human study presented at the Society of Nuclear Medicine and Molecular Imaging 2020 Annual Meeting has demonstrated the safety, favorable pharmacokinetic and dosimetry profile of 64Cu-EBRGD, a new, relatively long-lived PET tracer, in patients with glioblastomas.

13 Jul 2020

Researchers develop new approach to assess changes in tumor microenvironment

Research has shown that the tumor microenvironment (TME) can help cancers grow and evade the immune response. The TME has even been shown to inhibit cellular immunotherapy, a novel form of treatment in which the cells of a patient's immune system are re-engineered in the lab to attack cancer cells.

12 Jul 2020

First extensive review of COVID-19's effects on all affected organs outside the lungs

After only a few days caring for critically ill COVID-19 patients at the start of the outbreak in New York City, Aakriti Gupta, MD, realized that this was much more than a respiratory disease.

12 Jul 2020

Newly identified gene variants in Black Americans could lead to precision prostate cancer therapies

Black men in the United States are known to suffer disproportionately from prostate cancer, but few studies have investigated whether genetic differences in prostate tumors could have anything to do with these health disparities.

11 Jul 2020

Innovative system aims to improve predictions of survival indicators in breast cancer patients

Improving the predictions of survival indicators in breast cancer patients through artificial intelligence and probabilistic modeling tools is the goal of ModGraProDep, an innovative system presented in a study published in the journal Artificial Intelligence in Medicine.

11 Jul 2020

Researchers set up Gate2Brain to exploit a novel drug-transporting technology

Researchers from IRB Barcelona, the University of Barcelona (UB) and the Sant Joan de Déu Research Institute - Hospital Sant Joan de Déu (SJD) have set up Gate2Brain, a company based on a novel technology developed at IRB Barcelona to transport drugs into the brain.

10 Jul 2020

Upcoming phase II study to discover personalized therapy for patients at high risk for breast cancer relapse

Indiana University School of Medicine researchers Milan Radovich, PhD, and Bryan Schneider, MD, have discovered that the presence of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) in the plasma of women's blood who have undergone chemotherapy prior to surgery for the treatment of stage 1, 2 or 3 triple negative breast cancer are critical indicators for the prediction of disease recurrence and disease-free survival.

10 Jul 2020

New silicone rubber face mask can be easily sterilized and worn many times

Researchers at MIT and Brigham and Women's Hospital have designed a new face mask that they believe could stop viral particles as effectively as N95 masks.

9 Jul 2020

UHN leads first-of-its-kind real world evidence study of medical cannabis

Medical cannabis is finally being put under the microscope, in a first-of-its-kind real world evidence study led by Dr. Hance Clarke, Director of Pain Services, Toronto General Hospital, and a recognized leader in educating Canadians about chronic pain management and the risk factors of continued opioid use.

9 Jul 2020

Oncology News and Research

Further Reading

Rare inherited mutation in TP53 gene confers risk of multiple cancers

NCI funds research surrounding sustainability of telemedicine for rural cancer patients

Stand Up To Cancer announces new effort to achieve health equity for underserved lung cancer patients

Promising new CAR T cell therapy results in exceptional patient recovery

Novotech webinar focuses on how to advance oncology clinical trials in the Asia-Pacific

10x Genomics launches Chromium Single Cell Immune Profiling v2 product to fight COVID-19

Ashion's GEM ExTra assay receives Medicare coverage

MD Anderson and Sanofi collaborate to accelerate development of innovative cancer therapies

Two new studies highlight possible treatment options for patients with neuroendocrine tumors

PSMA PET/CT has high impact in the detection, management of recurrent prostate cancer

Total-body dynamic PET can generate high-quality images of metastatic cancer

Study shows safety and effectiveness of PET radiotracer in imaging glioblastomas

Researchers develop new approach to assess changes in tumor microenvironment

First extensive review of COVID-19's effects on all affected organs outside the lungs

Newly identified gene variants in Black Americans could lead to precision prostate cancer therapies

Innovative system aims to improve predictions of survival indicators in breast cancer patients

Researchers set up Gate2Brain to exploit a novel drug-transporting technology

Upcoming phase II study to discover personalized therapy for patients at high risk for breast cancer relapse

New silicone rubber face mask can be easily sterilized and worn many times

UHN leads first-of-its-kind real world evidence study of medical cannabis

A best-practice guide for laboratory services in oncology trials eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News